Comment on Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval

Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval

The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News